Latest Articles
Endometrial Cancer: Counseling on dMMR vs pMMR - Explaining Survival Advantage and Clinical Expectations - OncLive
Endometrial Cancer: Counseling on dMMR vs pMMR - Explaining Survival Advantage and Clinical Expectations OncLive
Published: Dec. 26, 2025, 1:19 p.m.
After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... - MSN
After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... MSN
Published: Dec. 25, 2025, 7:50 p.m.
Study Explores Cancer-Like Traits in Endometriosis Including Abnormal Cell Growth and Tissue Invasion - geneonline.com
Study Explores Cancer-Like Traits in Endometriosis Including Abnormal Cell Growth and Tissue Invasion geneonline.com
Published: Dec. 23, 2025, 8:37 p.m.
Endometriosis: Unveiling Its Cancer Hallmarks - BIOENGINEER.ORG
Endometriosis: Unveiling Its Cancer Hallmarks BIOENGINEER.ORG
Published: Dec. 23, 2025, 8:14 p.m.
Endometriosis: Unveiling Its Cancer Hallmarks - Bioengineer.org
Endometriosis: Unveiling Its Cancer Hallmarks Bioengineer.org
Published: Dec. 23, 2025, 8:14 p.m.
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer - Targeted Oncology
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer Targeted Oncology
Published: Dec. 23, 2025, 2:07 p.m.
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer - Investing.com Nigeria
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer Investing.com Nigeria
Published: Dec. 23, 2025, 2:36 a.m.
Nab-Sirolimus Plus Letrozole Shows Early Activity in Advanced/Recurrent Endometrioid Endometrial Cancer - OncLive
Nab-Sirolimus Plus Letrozole Shows Early Activity in Advanced/Recurrent Endometrioid Endometrial Cancer OncLive
Published: Dec. 22, 2025, 7:02 p.m.
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Dec. 22, 2025, 1:15 p.m.
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial - marketscreener.com
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial marketscreener.com
Published: Dec. 22, 2025, 11:40 a.m.
Link copied to clipboard!